LEADER 01527nam  2200445Ia 450 
001 9910699545603321
005 20230902162251.0
035   $a(CKB)5470000002403471
035   $a(OCoLC)710812180
035   $a(EXLCZ)995470000002403471
100   $a20110401d2010      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDistribution of oxycodone in postmortem fluids and tissues$b[electronic resource] /$fSabra R. Botch ... [and others]
210  1$aWashington, D.C. :$cOffice of Aerospace Medicine, Federal Aviation Administration,$d[2010]
215   $a1 online resource (iii, 5 pages)
300   $aTitle from title screen (viewed Mar. 31, 2011).
300   $a"June 2010."
300   $a"DOT/FAA/AM-10/11."
320   $aIncludes bibliographical references (pages 4-5).
606   $aOxycodone
606   $aAviation toxicology
606   $aForensic toxicology
606   $aAircraft accidents$xInvestigation
615  0$aOxycodone.
615  0$aAviation toxicology.
615  0$aForensic toxicology.
615  0$aAircraft accidents$xInvestigation.
701   $aBotch$b Sabra R$01401363
712 02$aUnited States.$bOffice of Aerospace Medicine.
712 02$aCivil Aerospace Medical Institute.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699545603321
996   $aDistribution of oxycodone in postmortem fluids and tissues$93470047
997   $aUNINA